Citadel Advisors
NUTX

Citadel Advisors’s Nutex Health NUTX Stock Holding History

Citadel Advisors’s Portfolio NUTX Stock Details NUTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.13M Buy
+18,315
New +$2.32M ﹤0.01% 5620
2025
Q3 		– Sell
-6,737
Closed -$839K – 13688
2025
Q2 		$839K Buy
+6,737
New +$870K ﹤0.01% 7475
2022
Q3 		– Sell
-1,735
Closed -$839K – 13286
2022
Q2 		$839K Buy
+1,735
New +$2.05M ﹤0.01% 7441

Other funds holding NUTX

PP
Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
WC
Winmill & Co Walpole, New Hampshire $452M AUM 56.84% 1-Year Est. Return
Focus Partners Wealth
Focus Partners Wealth Boston, Massachusetts $97.6B AUM 29.43% 1-Year Est. Return

Citadel Advisors's NUTX Position: Q2 2026 in Review

Citadel Advisors opened a new position in Nutex Health (NUTX) in Q2 2026: 18,315 shares worth $3.13M. The stake represents ﹤0.01% of the portfolio and ranks #5620 among its holdings. This is a return to the name: Citadel Advisors previously reported a position in NUTX as recently as Q2 2025.

Citadel Advisors first reported a position in NUTX in Q2 2022 and has held it in 3 quarters since. 154 funds tracked by Wall St. Rank hold NUTX as of Q2 2026.

  • Citadel Advisors held 18,315 shares of Nutex Health worth $3.13M as of Q2 2026.
  • Nutex Health was a new Citadel Advisors position in Q2 2026.
  • Nutex Health made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #5620 holding.
  • Citadel Advisors first reported a position in Nutex Health in Q2 2022 and has held it in 3 quarters since.
  • 154 funds tracked by Wall St. Rank held Nutex Health as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.